E
Canadian GoldCamps Corp. CAMP
CNSX
Recommendation
Sell
Prev Close
$0.25
Volume
--
Avg Vol (90D)
0
Market Cap
$2.22M
Dividend & Yield
--
52-Week Range
$0.25 - $0.26
P/E (TTM)
--
EPS (TTM)
-$0.1223
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
E+
Very Weak
Rating Factors
Growth Index
Very Weak
Efficiency Index
Very Weak
Solvency Index
Very Weak
Total Return Index
Weak
Volatility Index
Very Weak
Dividend Index
--
Headlines
Camp4 Therapeutics appoints Williams, Stewart to board of directors
3/18/2025 - The Fly
CAMP4 Appoints Multiple Industry Veterans to its Board of Directors
3/18/2025 - Globe Newswire
CAMP4 Therapeutics Corporation (CAMP): Among Penny Stocks with Insider Buying in 2025
3/4/2025 - Insider Monkey
12 Penny Stocks with Insider Buying in 2025
3/4/2025 - Insider Monkey
CAMP4 to Participate in Upcoming Investor Conferences
2/6/2025 - Globe Newswire
CAMP4 to Present at the 43rd Annual J.P. Morgan Healthcare Conference
1/13/2025 - Globe Newswire
Camp4 Therapeutics sees MAD safety and key biomarker data in 2H25
1/7/2025 - The Fly
CAMP4 Provides Corporate Updates and Highlights Key Upcoming Milestones
1/7/2025 - Globe Newswire
Analysts Forecast 26% Gains Ahead For VTWG
12/26/2024 - ETF Channel
Camp4 Therapeutics appoints Maraganore, Meyers are strategic advisors
12/10/2024 - TipRanks Financial Blog
Camp4 Therapeutics appoints Maraganore, Meyers are strategic advisors
12/10/2024 - The Fly
CAMP4 Appoints John Maraganore and Rachel Meyers as Strategic Advisors
12/10/2024 - Globe Newswire
Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), Monte Rosa Therapeutics (GLUE) and CAMP4 Therapeutics Corporation (CAMP)
12/6/2024 - TipRanks Financial Blog
CAMP4 Therapeutics Corp trading resumes
12/5/2024 - TipRanks Financial Blog
CAMP4 Therapeutics Corp trading resumes
12/5/2024 - The Fly
CAMP4 Therapeutics Corp trading halted, volatility trading pause
12/5/2024 - TipRanks Financial Blog
CAMP4 Therapeutics Corp trading halted, volatility trading pause
12/5/2024 - The Fly
CAMP4 to Participate in the Piper Sandler 36th Annual Healthcare Conference
12/2/2024 - Globe Newswire
Camp4 Therapeutics GAAP EPS of -$24.19
11/21/2024 - SeekingAlpha.com: All News
Camp4 Therapeutics reports Q3 EPS ($24.19) vs.($29.21) last year
11/21/2024 - TipRanks Financial Blog
Camp4 Therapeutics reports Q3 EPS ($24.19) vs.($29.21) last year
11/21/2024 - The Fly
CAMP4 Reports Third Quarter 2024 Financial Results
11/21/2024 - Globe Newswire
CAMP4 Analyst Highlights Rare Disease Platform Potential
11/5/2024 - Benzinga
Camp4 Therapeutics initiated with bullish view at Leerink, here's why
11/5/2024 - The Fly
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
-$1.49M
Net Income (TTM)
-$1.54M
Balance Sheet
Total Assets (Q)
$6.40K
Total Debt (Q)
$82.50K
Total Liabilities (Q)
$283.60K
Book Value Per Share (Q)
-$0.0218
Cash Flow
Cash from Operations (TTM)
-$104.60K
Cash from Investing (TTM)
$0.00
Cash from Financing (TTM)
$78.00K
Net Change in Cash (TTM)
-$26.50K
Filings
Filing Date
Tuesday, October 29, 2024
Period Date
Monday, September 30, 2024
Next Filing
Beginning of April (est)
Price History
Loading...
Beta
0.00
7-Day Total Return
0.00%
30-Day Total Return
0.00%
60-Day Total Return
0.00%
90-Day Total Return
0.00%
Year to Date Total Return
0.00%
1-Year Total Return
0.00%
2-Year Total Return
0.00%
3-Year Total Return
-40.48%
5-Year Total Return
-87.50%
52-week Low
Mar 17, 2025 - $0.25
52-week High
Mar 17, 2025 - $0.26
Valuation
Market Cap
$2.22M - Nano Cap
Enterprise Value
$2.30M
Price/Sales (TTM)
--
Price/Book (Q)
-11.47
Dividends and Shares
Shares Outstanding
12.70M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
--
Phone Number
Address
1075 West Georgia Street
Vancouver, BC V6E 3C9
Country
Canada
Year Founded
--
Business Description
Sector
Materials
Industry
Materials
Canadian GoldCamps Corp., an exploration stage company, engages in the acquisition, evaluation, and exploration of lithium properties. It holds agreements to acquire interests in the Valley... more
Weiss Ratings